Drug recall D-1040-2022
Product
Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg/2.5 mL, packaged in 25-count box (25 x 2.5 mL sterile unit-dose vials), Rx only, MFG: Nephron Pharma, NDC 0487-9801-25
Reason for recall
cGMP deviations: Temperature abuse
Lots and codes
McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Recall details
- Recalling firm
- Mckesson Medical-Surgical Inc. Corporate Office, Richmond, VA
- Quantity
- 57 pouches
- Distribution
- USA nationwide.
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 13, 2022
- Terminated
- November 30, 2023
Related products
- Ipratropium bromide – drug information
- NDC 0487-9801 Ipratropium Bromide · Ipratropium Bromide .5 mg/2.5mL · Nephron Pharmaceuticals Corporation